In a 19-year-old male with no cardiac history who has been newly diagnosed with ADHD and whose resting ECG shows sinus bradycardia, are there any contraindications to initiating stimulant therapy with lisdexamfetamine (Vyvanse)?

Sinus Bradycardia is NOT a Contraindication to Starting Vyvanse in This Patient

In this 19-year-old male with no cardiac history and incidental sinus bradycardia on ECG, you can safely initiate Vyvanse (lisdexamfetamine) for ADHD treatment. The bradycardia alone does not constitute a contraindication, but you must first rule out underlying structural cardiac disease through targeted history-taking.

Key Clinical Reasoning

What the FDA Label Actually Says

The Vyvanse FDA label specifically states to "avoid use in patients with known structural cardiac abnormalities, cardiomyopathy, serious cardiac arrhythmia, coronary artery disease, or other serious cardiac disease" 1. Notably, sinus bradycardia is not listed as a contraindication or serious cardiac arrhythmia requiring avoidance. The actual contraindications are limited to hypersensitivity reactions and concurrent MAOI use 1.

Why Sinus Bradycardia Alone Doesn't Disqualify This Patient

• Stimulants typically increase heart rate by 3-6 bpm on average 2, which could theoretically normalize or improve bradycardia
• The concern with stimulants is tachyarrhythmias and hypertension, not bradycardia 1
• Sinus bradycardia in a young, asymptomatic individual is often physiologic (especially in athletes) and not pathologic

What You Must Do Before Prescribing

Current guidelines emphasize targeted cardiac screening through history alone—not routine ECG 3, 2. Since you already have an ECG showing bradycardia, your next step is to determine if this represents benign physiology or underlying pathology:

Essential screening questions 2:

• Personal history: Syncope, chest pain, palpitations, exercise intolerance, seizures
• Family history: Sudden unexplained death before age 50, Wolff-Parkinson-White syndrome, hypertrophic cardiomyopathy, long QT syndrome, arrhythmias
• Physical examination: Heart murmurs, irregular rhythm, signs of cardiomyopathy

If all screening is negative (no symptoms, no concerning family history, normal physical exam aside from bradycardia), the patient can start Vyvanse with appropriate monitoring.

If any red flags are present, obtain cardiology consultation before initiating stimulants 2.

Important Caveats

The ECG Paradox

The 2009 Canadian consensus and 2019 AAP guidelines explicitly state that "routine ECG assessment of ADHD patients before starting medication is not supported by evidence and is not recommended" 3, 2. This patient already has an ECG, so the question becomes whether the incidental finding changes management. The answer: only if it suggests underlying structural disease requiring further workup.

Monitoring After Initiation

Once started on Vyvanse:

• Monitor heart rate and blood pressure at each visit 2, 1
• Expect modest increases in HR (mean 3-6 bpm) and BP (2-4 mmHg) 2
• Watch for pulse outliers (≥100 bpm), which occur in 3-8% of patients 4
• The bradycardia may actually improve with stimulant therapy

Safety Data Supporting This Approach

• Large population studies show no increased risk of sudden cardiac death with stimulants compared to the general population 3, 5
• A 2022 study of 45,679 LDX users found no increased cardiovascular or cerebrovascular events compared to other ADHD medications 6
• Lisdexamfetamine specifically has been shown to have limited short-term effects on cardiac parameters in healthy adults 4

Alternative Consideration

If you remain concerned about the bradycardia despite negative screening, non-stimulant options (atomoxetine, guanfacine, clonidine) are NOT better choices here. Guanfacine and clonidine actually decrease heart rate and can cause bradycardia 2, making them potentially worse options. Atomoxetine increases heart rate but has similar cardiovascular monitoring requirements 2.

Bottom Line Algorithm

1. Complete targeted cardiac history and physical exam (symptoms, family history, murmurs)
2. If screening is negative: Start Vyvanse with standard monitoring
3. If any red flags: Refer to cardiology before initiating any ADHD medication
4. Monitor HR/BP regularly after starting treatment
5. The bradycardia itself is not a contraindication 1

The evidence strongly supports that asymptomatic sinus bradycardia in a young adult without structural heart disease does not preclude stimulant therapy 3, 2, 4, 6.